| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.004 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.007 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.096 | 0.007 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.008 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.008 |